Developing an Irreversible Inhibitor of Human DDAH-1, an Enzyme Upregulated in Melanoma-Reference-Cited by-同舟云学术

Developing an Irreversible Inhibitor of Human DDAH-1, an Enzyme Upregulated in Melanoma

Published:2014-02-26 Issue:4 Volume:9 Page:792-797
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Wang Yun,Hu Shougang,Gabisi Abdul M.,Er Joyce A. V.,Pope Arthur,Burstein Gayle,Schardon Christopher L.,Cardounel Arturo J.,Ekmekcioglu Suhendan,Fast Walter

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Reference40 articles.

1. The therapeutic potential of targeting endogenous inhibitors of nitric oxide synthesis

2. Endogenous Nitric Oxide Synthase Inhibitors in the Biology of Disease

3. Curr. Pharm. Des. 2013

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in DDAH1 inhibitor design and discovery: insights from structure–activity relationships and X-ray crystal structures;RSC Advances;2024

2. Development of a HPLC-MS/MS Method to Assess the Pharmacokinetics and Tumour Distribution of the Dimethylarginine Dimethylaminohydrolase 1 Inhibitors ZST316 and L-257 in a Xenograft Model of Triple-Negative Breast Cancer in Mice;Molecules;2023-12-13

3. Dimethylarginine Dimethylaminohydrolase - 1 expression is increased under tBHP-induced oxidative stress regulates nitric oxide production in PCa cells attenuates mitochondrial ROS-mediated apoptosis;Nitric Oxide;2023-09

4. Tumor cell-derived asymmetric dimethylarginine regulates macrophage functions and polarization;Cancer Cell International;2022-11-15